Menu
Back to User profile » Prof. Dr. Kenji Inoue
Papers published by Prof. Dr. Kenji Inoue:
Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil
Inoue K, Shiokawa M, Kunimatsu-Sanuki S, Tomita G, Ishida K
Clinical Ophthalmology 2024, 18:423-430
Published Date: 7 February 2024
Frequency of Use of Fixed-Combination Eye Drops by Patients with Glaucoma at Multiple Private Practices in Japan
Inoue K, Komori R, Kunimatsu-Sanuki S, Ishida K, Tomita G
Clinical Ophthalmology 2022, 16:557-565
Published Date: 1 March 2022
Short-Term Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Inoue K, Inoue J, Kunimatsu-Sanuki S, Nozaki N, Shimizu K, Ishida K, Tomita G
Clinical Ophthalmology 2020, 14:2943-2949
Published Date: 30 September 2020
Short-Term Efficacy and Safety of Switching from a Latanoprost/Timolol Fixed Combination to a Latanoprost/Carteolol Fixed Combination
Inoue K, Piao H, Iwasa M, Ishida K, Tomita G
Clinical Ophthalmology 2020, 14:1207-1214
Published Date: 4 May 2020
Switching from concomitant therapy to tafluprost/timolol fixed combination
Inoue K, Kawashima T, Katakura S, Shidara K, Fujimoto T, Kohmoto H, Shiokawa M, Moriyama R, Okayama R
Clinical Ophthalmology 2018, 12:549-554
Published Date: 21 March 2018
Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
Inoue K, Shiokawa M, Ishida K, Tomita G
Clinical Ophthalmology 2015, 9:619-623
Published Date: 9 April 2015
Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
Inoue K, Okayama R, Higa R, Tomita G
Clinical Ophthalmology 2014, 8:1275-1279
Published Date: 3 July 2014
Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma
Inoue K, Shiokawa M, Fujimoto T, Tomita G
Clinical Ophthalmology 2014, 8:1179-1183
Published Date: 19 June 2014
Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
Inoue K, Tanaka A, Tomita G
Clinical Ophthalmology 2013, 7:1411-1416
Published Date: 9 July 2013
Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
Inoue K, Iwasa M, Wakakura M, Tomita G
Clinical Ophthalmology 2012, 6:1315-1319
Published Date: 15 August 2012
Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
Inoue K, Fujimoto T, Higa R, Moriyama R, Kohmoto H, Nagumo H, Wakakura M, Tomita G
Clinical Ophthalmology 2012, 6:771-775
Published Date: 21 May 2012
Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
Inoue K, Okayama R, Higa R, Wakakura M, Tomita G
Clinical Ophthalmology 2012, 6:607-612
Published Date: 18 April 2012
Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from ß-blockers and prostaglandin analogs
Inoue K, Setogawa A, Higa R, Moriyama R, Wakakura M, Tomita G
Clinical Ophthalmology 2012, 6:231-235
Published Date: 10 February 2012
Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
Inoue K, Shiokawa M, Sugahara M, Higa R, Wakakura M, Tomita G
Clinical Ophthalmology 2012, 6:111-116
Published Date: 12 January 2012
Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma
Inoue K, Noguchi K, Wakakura M, Tomita G
Clinical Ophthalmology 2011, 5:1211-1216
Published Date: 26 August 2011
Effects of unoprostone on diurnal variation of intraocular pressure in healthy volunteers
Inoue K, Noguchi K, Wakakura M, Tomita G
Clinical Ophthalmology 2011, 5:1003-1005
Published Date: 15 July 2011